Flurbiprofen Sodium

氟吡洛芬钠

Report date: 2022/04/07 16:43:02
NME

Base Information

Drug NameFlurbiprofen Sodium
Drug Alias Name氟比洛芬flurbiprofenumflurbiprofeno氟比洛芬钠Ocufen +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPainMiosisOsteoarthritis, Knee +[6] 
Global Approved IndicationsPainMiosisOsteoarthritis +[5] 
Approved Indications in ChinaPainOsteoarthritisArthritis, Rheumatoid +[4] 
Original Approved Country/TerritoryUnited States
Original Approved Date1986/12/31
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Tide Pharmaceutical Co LtdMikasa Seiyaku Co LtdShanghai Zhongxi Sunve Pharmaceutical Co Ltd +[4] 
Inactive CompaniesAllergan Plc
Active IndicationsPainOsteoarthritis, KneeOsteoarthritis +[5] 
Inactive IndicationsMiosis

Other Information

ATC CodeM01AE09M02AA19R02AX01 +[4] 
Related LinksWikipediaDrugBankKEGG